[1]
Syfridiana, R. and Herawati, F. 2021. Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy . Journal of Health Sciences. 14, 3 (Aug. 2021), 214–221. DOI:https://doi.org/10.33086/jhs.v14i3.2114.